Fortress Biotech, Inc. - 9.375% (FBIOP) Financials
FBIOP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 150.5 million | 163.8 million |
| 2023-06-30 | 180.7 million | 196.7 million |
| 2023-03-31 | 263.6 million | 243.7 million |
| 2022-12-31 | 294.3 million | 244.3 million |
FBIOP Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -17.8 million | 4.4 million |
| 2023-06-30 | -33.3 million | 4.2 million |
| 2023-03-31 | -43.2 million | 4.7 million |
| 2022-12-31 | -48.2 million | 5.5 million |
FBIOP Net Income
No data available :(
FBIOP Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 72.3 million | - | 21.4 million |
| 2023-06-30 | 78.0 million | - | 21.8 million |
| 2023-03-31 | 152.5 million | - | 23.5 million |
| 2022-12-31 | 178.3 million | - | 24.0 million |
FBIOP Shares Outstanding
FBIOP Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 1.0 million | 20.3 million | 21.7 million | - |
| 2023-06-30 | 34000 | 32.1 million | 24.4 million | - |
| 2023-03-31 | 18000 | 39.5 million | 25.3 million | - |
| 2022-12-31 | 391000 | 35.1 million | 28.2 million | - |
FBIOP Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 34.8 million | 6.4 million |
| 2023-06-30 | 17.4 million | 7.8 million |
| 2023-03-31 | 12.4 million | 6.4 million |
| 2022-12-31 | 16.4 million | 7.7 million |
FBIOP
Price: $15.55
Forward Dividend Yield: 15.07%
Payout Ratio: -271.58%
Dividend Per Share: 2.34 USD
Earnings Per Share: -0.86 USD
P/E Ratio: -15.64
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 15415
Market Capitalization: 93.9 million
Average Dividend Frequency: 9
Years Paying Dividends: 8